Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
DLX1
|
ENSG00000144355.10 | distal-less homeobox 1 |
HOXA3
|
ENSG00000105997.18 | homeobox A3 |
BARX2
|
ENSG00000043039.5 | BARX homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BARX2 | hg19_v2_chr11_+_129245796_129245835 | 0.50 | 4.0e-03 | Click! |
DLX1 | hg19_v2_chr2_+_172949468_172949522 | 0.49 | 4.1e-03 | Click! |
HOXA3 | hg19_v2_chr7_-_27153454_27153469 | 0.31 | 8.9e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_151503077 | 2.04 |
ENST00000317605.4
|
MAB21L2
|
mab-21-like 2 (C. elegans) |
chr2_-_89161432 | 1.93 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
chr4_-_138453606 | 1.61 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
chr17_-_38821373 | 1.58 |
ENST00000394052.3
|
KRT222
|
keratin 222 |
chr4_+_88896819 | 1.57 |
ENST00000237623.7
ENST00000395080.3 ENST00000508233.1 ENST00000360804.4 |
SPP1
|
secreted phosphoprotein 1 |
chr3_+_43020773 | 1.54 |
ENST00000488863.1
|
FAM198A
|
family with sequence similarity 198, member A |
chr13_+_53602894 | 1.52 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chr4_+_71063641 | 1.43 |
ENST00000514097.1
|
ODAM
|
odontogenic, ameloblast asssociated |
chrX_-_13835147 | 1.40 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
chr3_+_2933893 | 1.38 |
ENST00000397459.2
|
CNTN4
|
contactin 4 |
chr4_-_87028478 | 1.36 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr15_+_69857515 | 1.34 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
chr9_-_95166976 | 1.32 |
ENST00000447356.1
|
OGN
|
osteoglycin |
chr14_+_95027772 | 1.30 |
ENST00000555095.1
ENST00000298841.5 ENST00000554220.1 ENST00000553780.1 |
SERPINA4
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr9_-_95166884 | 1.26 |
ENST00000375561.5
|
OGN
|
osteoglycin |
chrX_-_18690210 | 1.26 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
chr9_-_95166841 | 1.24 |
ENST00000262551.4
|
OGN
|
osteoglycin |
chr4_-_175041663 | 1.23 |
ENST00000503140.1
|
RP11-148L24.1
|
RP11-148L24.1 |
chr15_-_37393406 | 1.19 |
ENST00000338564.5
ENST00000558313.1 ENST00000340545.5 |
MEIS2
|
Meis homeobox 2 |
chr12_-_15374343 | 1.19 |
ENST00000256953.2
ENST00000546331.1 |
RERG
|
RAS-like, estrogen-regulated, growth inhibitor |
chr1_-_190446759 | 1.17 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
chr11_+_24518723 | 1.14 |
ENST00000336930.6
ENST00000529015.1 ENST00000533227.1 |
LUZP2
|
leucine zipper protein 2 |
chr15_+_58702742 | 1.07 |
ENST00000356113.6
ENST00000414170.3 |
LIPC
|
lipase, hepatic |
chr10_-_50970382 | 1.07 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
chr8_+_70476088 | 1.06 |
ENST00000525999.1
|
SULF1
|
sulfatase 1 |
chr2_+_234826016 | 1.06 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr10_-_50970322 | 1.04 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
chr14_+_85994943 | 1.03 |
ENST00000553678.1
|
RP11-497E19.2
|
Uncharacterized protein |
chr11_+_101918153 | 1.02 |
ENST00000434758.2
ENST00000526781.1 ENST00000534360.1 |
C11orf70
|
chromosome 11 open reading frame 70 |
chr4_-_138453559 | 0.99 |
ENST00000511115.1
|
PCDH18
|
protocadherin 18 |
chr16_+_82090028 | 0.99 |
ENST00000568090.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr2_+_228736335 | 0.97 |
ENST00000440997.1
ENST00000545118.1 |
DAW1
|
dynein assembly factor with WDR repeat domains 1 |
chrX_-_73051037 | 0.97 |
ENST00000445814.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr1_+_81771806 | 0.96 |
ENST00000370721.1
ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2
|
latrophilin 2 |
chr4_-_176812842 | 0.96 |
ENST00000507540.1
|
GPM6A
|
glycoprotein M6A |
chr13_+_110958124 | 0.94 |
ENST00000400163.2
|
COL4A2
|
collagen, type IV, alpha 2 |
chrX_-_110507098 | 0.94 |
ENST00000541758.1
|
CAPN6
|
calpain 6 |
chr3_+_111717511 | 0.93 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr4_-_186570679 | 0.93 |
ENST00000451974.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr12_-_22063787 | 0.92 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chrX_-_50386648 | 0.91 |
ENST00000460112.3
|
SHROOM4
|
shroom family member 4 |
chr4_-_69536346 | 0.91 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
chr3_+_111717600 | 0.90 |
ENST00000273368.4
|
TAGLN3
|
transgelin 3 |
chr12_-_23737534 | 0.90 |
ENST00000396007.2
|
SOX5
|
SRY (sex determining region Y)-box 5 |
chr1_+_196743943 | 0.89 |
ENST00000471440.2
ENST00000391985.3 |
CFHR3
|
complement factor H-related 3 |
chr8_-_86290333 | 0.89 |
ENST00000521846.1
ENST00000523022.1 ENST00000524324.1 ENST00000519991.1 ENST00000520663.1 ENST00000517590.1 ENST00000522579.1 ENST00000522814.1 ENST00000522662.1 ENST00000523858.1 ENST00000519129.1 |
CA1
|
carbonic anhydrase I |
chr3_+_28390637 | 0.88 |
ENST00000420223.1
ENST00000383768.2 |
ZCWPW2
|
zinc finger, CW type with PWWP domain 2 |
chr2_-_89161064 | 0.88 |
ENST00000390241.2
|
IGKJ2
|
immunoglobulin kappa joining 2 |
chr3_+_111718036 | 0.87 |
ENST00000455401.2
|
TAGLN3
|
transgelin 3 |
chr7_+_99717230 | 0.85 |
ENST00000262932.3
|
CNPY4
|
canopy FGF signaling regulator 4 |
chr2_-_224467093 | 0.85 |
ENST00000305409.2
|
SCG2
|
secretogranin II |
chr4_-_46126093 | 0.85 |
ENST00000295452.4
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
chr7_-_7575477 | 0.84 |
ENST00000399429.3
|
COL28A1
|
collagen, type XXVIII, alpha 1 |
chr7_-_107443652 | 0.84 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
chr19_+_45417921 | 0.83 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr2_-_183387064 | 0.82 |
ENST00000536095.1
ENST00000331935.6 ENST00000358139.2 ENST00000456212.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr17_-_64225508 | 0.81 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr20_+_56136136 | 0.80 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr1_+_161190160 | 0.80 |
ENST00000594609.1
|
AL590714.1
|
Uncharacterized protein |
chr5_-_173217916 | 0.80 |
ENST00000523617.1
|
CTB-43E15.4
|
CTB-43E15.4 |
chr7_-_99716914 | 0.80 |
ENST00000431404.2
|
TAF6
|
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa |
chr4_-_176733377 | 0.79 |
ENST00000505375.1
|
GPM6A
|
glycoprotein M6A |
chr8_+_98900132 | 0.79 |
ENST00000520016.1
|
MATN2
|
matrilin 2 |
chr1_+_160370344 | 0.78 |
ENST00000368061.2
|
VANGL2
|
VANGL planar cell polarity protein 2 |
chr6_+_25652432 | 0.78 |
ENST00000377961.2
|
SCGN
|
secretagogin, EF-hand calcium binding protein |
chr17_+_1674982 | 0.77 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr2_+_228736321 | 0.75 |
ENST00000309931.2
|
DAW1
|
dynein assembly factor with WDR repeat domains 1 |
chrX_+_43515467 | 0.74 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chr14_-_94789663 | 0.74 |
ENST00000557225.1
ENST00000341584.3 |
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
chr6_+_149721495 | 0.73 |
ENST00000326669.4
|
SUMO4
|
small ubiquitin-like modifier 4 |
chr14_+_101359265 | 0.73 |
ENST00000599197.1
|
AL117190.3
|
Esophagus cancer-related gene-2 interaction susceptibility protein; Uncharacterized protein |
chr8_-_49834299 | 0.73 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr4_-_185275104 | 0.72 |
ENST00000317596.3
|
RP11-290F5.2
|
RP11-290F5.2 |
chr5_-_173217931 | 0.71 |
ENST00000522731.1
|
CTB-43E15.4
|
CTB-43E15.4 |
chr3_-_100565249 | 0.71 |
ENST00000495591.1
ENST00000383691.4 ENST00000466947.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr19_-_36001113 | 0.71 |
ENST00000434389.1
|
DMKN
|
dermokine |
chr2_-_224467002 | 0.71 |
ENST00000421386.1
ENST00000433889.1 |
SCG2
|
secretogranin II |
chr5_-_160279207 | 0.70 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
chr5_+_140529630 | 0.70 |
ENST00000543635.1
|
PCDHB6
|
protocadherin beta 6 |
chr8_-_66474884 | 0.70 |
ENST00000520902.1
|
CTD-3025N20.2
|
CTD-3025N20.2 |
chr10_-_135379132 | 0.69 |
ENST00000343131.5
|
SYCE1
|
synaptonemal complex central element protein 1 |
chr4_-_16675930 | 0.69 |
ENST00000503178.2
|
LDB2
|
LIM domain binding 2 |
chr8_+_92261516 | 0.69 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
chr11_-_117748138 | 0.68 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr4_+_70796784 | 0.68 |
ENST00000246891.4
ENST00000444405.3 |
CSN1S1
|
casein alpha s1 |
chr8_-_86253888 | 0.68 |
ENST00000522389.1
ENST00000432364.2 ENST00000517618.1 |
CA1
|
carbonic anhydrase I |
chr15_+_43886057 | 0.67 |
ENST00000441322.1
ENST00000413657.2 ENST00000453733.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr11_-_13517565 | 0.66 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chr1_+_86934526 | 0.66 |
ENST00000394711.1
|
CLCA1
|
chloride channel accessory 1 |
chr14_-_67878917 | 0.66 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
chr4_-_69434245 | 0.66 |
ENST00000317746.2
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17 |
chr15_+_43985725 | 0.66 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr3_-_120400960 | 0.66 |
ENST00000476082.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chr7_+_134528635 | 0.65 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
chr10_-_128110441 | 0.65 |
ENST00000456514.1
|
LINC00601
|
long intergenic non-protein coding RNA 601 |
chr3_+_149191723 | 0.65 |
ENST00000305354.4
|
TM4SF4
|
transmembrane 4 L six family member 4 |
chr7_+_142982023 | 0.63 |
ENST00000359333.3
ENST00000409244.1 ENST00000409541.1 ENST00000410004.1 |
TMEM139
|
transmembrane protein 139 |
chr6_+_25652501 | 0.63 |
ENST00000334979.6
|
SCGN
|
secretagogin, EF-hand calcium binding protein |
chr21_+_17442799 | 0.62 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr12_+_20963632 | 0.62 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr10_-_96829246 | 0.60 |
ENST00000371270.3
ENST00000535898.1 ENST00000539050.1 |
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8 |
chr12_-_15374328 | 0.60 |
ENST00000537647.1
|
RERG
|
RAS-like, estrogen-regulated, growth inhibitor |
chr14_+_24540046 | 0.60 |
ENST00000397016.2
ENST00000537691.1 ENST00000560356.1 ENST00000558450.1 |
CPNE6
|
copine VI (neuronal) |
chr2_+_191221240 | 0.60 |
ENST00000409027.1
ENST00000458193.1 |
INPP1
|
inositol polyphosphate-1-phosphatase |
chr12_-_48164812 | 0.58 |
ENST00000549151.1
ENST00000548919.1 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr11_-_26593649 | 0.58 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
chr16_+_82068585 | 0.57 |
ENST00000563491.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr4_-_186696425 | 0.57 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr12_-_16760021 | 0.57 |
ENST00000540445.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr19_+_58570605 | 0.56 |
ENST00000359978.6
ENST00000401053.4 ENST00000439855.2 ENST00000313434.5 ENST00000511556.1 ENST00000506786.1 |
ZNF135
|
zinc finger protein 135 |
chr2_+_108863651 | 0.55 |
ENST00000329106.2
ENST00000376700.1 |
SULT1C3
|
sulfotransferase family, cytosolic, 1C, member 3 |
chr10_-_105845674 | 0.55 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr11_+_27076764 | 0.55 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr11_+_65554493 | 0.55 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
chr10_+_5238793 | 0.55 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
chr12_-_15815626 | 0.54 |
ENST00000540613.1
|
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr3_+_111718173 | 0.54 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr5_-_42812143 | 0.54 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr11_-_117747434 | 0.53 |
ENST00000529335.2
ENST00000530956.1 ENST00000260282.4 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr5_-_41213607 | 0.53 |
ENST00000337836.5
ENST00000433294.1 |
C6
|
complement component 6 |
chr1_+_28261492 | 0.53 |
ENST00000373894.3
|
SMPDL3B
|
sphingomyelin phosphodiesterase, acid-like 3B |
chr5_-_137475071 | 0.53 |
ENST00000265191.2
|
NME5
|
NME/NM23 family member 5 |
chr5_+_140557371 | 0.52 |
ENST00000239444.2
|
PCDHB8
|
protocadherin beta 8 |
chr17_+_48823975 | 0.52 |
ENST00000513969.1
ENST00000503728.1 |
LUC7L3
|
LUC7-like 3 (S. cerevisiae) |
chr3_+_138340049 | 0.52 |
ENST00000464668.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
chr3_-_160823158 | 0.52 |
ENST00000392779.2
ENST00000392780.1 ENST00000494173.1 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr1_+_196743912 | 0.51 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
chr11_-_117747607 | 0.51 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr11_+_27015628 | 0.51 |
ENST00000318627.2
|
FIBIN
|
fin bud initiation factor homolog (zebrafish) |
chr11_-_111649074 | 0.51 |
ENST00000534218.1
|
RP11-108O10.2
|
RP11-108O10.2 |
chr2_+_201450591 | 0.50 |
ENST00000374700.2
|
AOX1
|
aldehyde oxidase 1 |
chr15_+_62853562 | 0.50 |
ENST00000561311.1
|
TLN2
|
talin 2 |
chr2_-_43266680 | 0.50 |
ENST00000425212.1
ENST00000422351.1 ENST00000449766.1 |
AC016735.2
|
AC016735.2 |
chr2_-_183387430 | 0.50 |
ENST00000410103.1
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr13_-_86373536 | 0.49 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
chr12_-_127544894 | 0.49 |
ENST00000546062.1
ENST00000512624.2 ENST00000540244.1 |
RP11-575F12.1
|
RP11-575F12.1 |
chr2_-_112237835 | 0.49 |
ENST00000442293.1
ENST00000439494.1 |
MIR4435-1HG
|
MIR4435-1 host gene (non-protein coding) |
chr16_+_82068873 | 0.48 |
ENST00000566213.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr1_-_201140673 | 0.48 |
ENST00000367333.2
|
TMEM9
|
transmembrane protein 9 |
chr10_-_135379074 | 0.48 |
ENST00000303903.6
|
SYCE1
|
synaptonemal complex central element protein 1 |
chr16_-_28937027 | 0.48 |
ENST00000358201.4
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr6_-_138833630 | 0.48 |
ENST00000533765.1
|
NHSL1
|
NHS-like 1 |
chr6_+_160542870 | 0.47 |
ENST00000324965.4
ENST00000457470.2 |
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr15_+_84115868 | 0.47 |
ENST00000427482.2
|
SH3GL3
|
SH3-domain GRB2-like 3 |
chr14_+_37641012 | 0.47 |
ENST00000556667.1
|
SLC25A21-AS1
|
SLC25A21 antisense RNA 1 |
chr3_-_151034734 | 0.47 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
chr6_+_160542821 | 0.47 |
ENST00000366963.4
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr4_-_66536057 | 0.47 |
ENST00000273854.3
|
EPHA5
|
EPH receptor A5 |
chr5_-_96478466 | 0.46 |
ENST00000274382.4
|
LIX1
|
Lix1 homolog (chicken) |
chr8_-_124741451 | 0.46 |
ENST00000520519.1
|
ANXA13
|
annexin A13 |
chr1_+_50575292 | 0.46 |
ENST00000371821.1
ENST00000371819.1 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr6_+_46761118 | 0.46 |
ENST00000230588.4
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase) |
chr7_-_44580861 | 0.45 |
ENST00000546276.1
ENST00000289547.4 ENST00000381160.3 ENST00000423141.1 |
NPC1L1
|
NPC1-like 1 |
chr9_+_130911723 | 0.45 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
chr10_-_13043697 | 0.45 |
ENST00000378825.3
|
CCDC3
|
coiled-coil domain containing 3 |
chr3_-_160823040 | 0.45 |
ENST00000484127.1
ENST00000492353.1 ENST00000473142.1 ENST00000468268.1 ENST00000460353.1 ENST00000320474.4 ENST00000392781.2 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr9_-_73477826 | 0.45 |
ENST00000396285.1
ENST00000396292.4 ENST00000396280.5 ENST00000358082.3 ENST00000408909.2 ENST00000377097.3 |
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr15_-_54051831 | 0.45 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
chrX_-_16887963 | 0.44 |
ENST00000380084.4
|
RBBP7
|
retinoblastoma binding protein 7 |
chr6_+_168418553 | 0.44 |
ENST00000354419.2
ENST00000351261.3 |
KIF25
|
kinesin family member 25 |
chr18_-_48351743 | 0.44 |
ENST00000588444.1
ENST00000256425.2 ENST00000428869.2 |
MRO
|
maestro |
chr3_+_115342349 | 0.44 |
ENST00000393780.3
|
GAP43
|
growth associated protein 43 |
chr7_+_150020363 | 0.43 |
ENST00000359623.4
ENST00000493307.1 |
LRRC61
|
leucine rich repeat containing 61 |
chr5_-_42811986 | 0.43 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr3_-_20053741 | 0.43 |
ENST00000389050.4
|
PP2D1
|
protein phosphatase 2C-like domain containing 1 |
chr2_-_169887827 | 0.43 |
ENST00000263817.6
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr3_-_164796269 | 0.43 |
ENST00000264382.3
|
SI
|
sucrase-isomaltase (alpha-glucosidase) |
chr17_-_19364269 | 0.43 |
ENST00000421796.2
ENST00000585389.1 ENST00000609249.1 |
AC004448.5
|
AC004448.5 |
chr10_+_7745232 | 0.42 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chr8_-_41166953 | 0.42 |
ENST00000220772.3
|
SFRP1
|
secreted frizzled-related protein 1 |
chr11_-_63376013 | 0.42 |
ENST00000540943.1
|
PLA2G16
|
phospholipase A2, group XVI |
chr7_-_150020750 | 0.42 |
ENST00000539352.1
|
ACTR3C
|
ARP3 actin-related protein 3 homolog C (yeast) |
chr1_-_242612779 | 0.41 |
ENST00000427495.1
|
PLD5
|
phospholipase D family, member 5 |
chr2_-_89160770 | 0.41 |
ENST00000390240.2
|
IGKJ3
|
immunoglobulin kappa joining 3 |
chr7_-_14029283 | 0.41 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
chr7_-_83278322 | 0.41 |
ENST00000307792.3
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
chr1_-_112032284 | 0.41 |
ENST00000414219.1
|
ADORA3
|
adenosine A3 receptor |
chr6_-_138866823 | 0.41 |
ENST00000342260.5
|
NHSL1
|
NHS-like 1 |
chr7_+_100547156 | 0.41 |
ENST00000379458.4
|
MUC3A
|
Protein LOC100131514 |
chr3_-_194072019 | 0.41 |
ENST00000429275.1
ENST00000323830.3 |
CPN2
|
carboxypeptidase N, polypeptide 2 |
chr12_-_71533055 | 0.41 |
ENST00000552128.1
|
TSPAN8
|
tetraspanin 8 |
chr7_-_82792215 | 0.41 |
ENST00000333891.9
ENST00000423517.2 |
PCLO
|
piccolo presynaptic cytomatrix protein |
chr11_-_129062093 | 0.41 |
ENST00000310343.9
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr4_+_80584903 | 0.41 |
ENST00000506460.1
|
RP11-452C8.1
|
RP11-452C8.1 |
chr12_-_16760195 | 0.40 |
ENST00000546281.1
ENST00000537757.1 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr14_-_25479811 | 0.40 |
ENST00000550887.1
|
STXBP6
|
syntaxin binding protein 6 (amisyn) |
chr21_-_31588365 | 0.40 |
ENST00000399899.1
|
CLDN8
|
claudin 8 |
chr10_+_7745303 | 0.40 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chr17_-_72772462 | 0.39 |
ENST00000582870.1
ENST00000581136.1 ENST00000357814.3 ENST00000579218.1 ENST00000583476.1 ENST00000580301.1 ENST00000583757.1 ENST00000582524.1 |
NAT9
|
N-acetyltransferase 9 (GCN5-related, putative) |
chr10_+_81891416 | 0.39 |
ENST00000372270.2
|
PLAC9
|
placenta-specific 9 |
chr18_+_61616510 | 0.39 |
ENST00000408945.3
|
HMSD
|
histocompatibility (minor) serpin domain containing |
chr6_-_112575912 | 0.39 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr9_-_75488984 | 0.39 |
ENST00000423171.1
ENST00000449235.1 ENST00000453787.1 |
RP11-151D14.1
|
RP11-151D14.1 |
chr5_+_63802109 | 0.39 |
ENST00000334025.2
|
RGS7BP
|
regulator of G-protein signaling 7 binding protein |
chr3_-_12587055 | 0.39 |
ENST00000564146.3
|
C3orf83
|
chromosome 3 open reading frame 83 |
chr4_-_34271356 | 0.39 |
ENST00000514877.1
|
RP11-548L20.1
|
RP11-548L20.1 |
chr6_-_169654139 | 0.38 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
chr4_-_150736962 | 0.38 |
ENST00000502345.1
ENST00000510975.1 ENST00000511993.1 |
RP11-526A4.1
|
RP11-526A4.1 |
chr19_+_49199209 | 0.38 |
ENST00000522966.1
ENST00000425340.2 ENST00000391876.4 |
FUT2
|
fucosyltransferase 2 (secretor status included) |
chr11_-_26593779 | 0.38 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.5 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.3 | 1.3 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.3 | 1.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 0.8 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 0.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 0.7 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.2 | 0.7 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.2 | 0.7 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.2 | 1.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 0.8 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.2 | 0.8 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.2 | 1.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 3.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 0.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.2 | 1.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.2 | 1.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.6 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.1 | 0.6 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.4 | GO:1904956 | neural crest cell fate commitment(GO:0014034) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 0.9 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 1.7 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 1.4 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.5 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 1.0 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.6 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.3 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.1 | 0.5 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.1 | 0.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 1.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 2.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 1.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 1.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.5 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.1 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.1 | 0.2 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.1 | 1.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.2 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 1.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.3 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.2 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.4 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.9 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.0 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.3 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 0.2 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.0 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.2 | GO:0061150 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.0 | 1.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 1.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.3 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.4 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 1.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 1.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.0 | 1.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.0 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 1.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 1.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 1.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 1.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.0 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.0 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 1.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.0 | 0.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.3 | GO:0007565 | female pregnancy(GO:0007565) |
0.0 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 2.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.5 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.4 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 1.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.0 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.0 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 1.0 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 1.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0097181 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.2 | 0.8 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.2 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.3 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.1 | 1.9 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 1.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 5.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 3.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 1.5 | GO:0044297 | cell body(GO:0044297) |
0.0 | 2.0 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.3 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.0 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 2.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 3.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.0 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.3 | 1.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.3 | 1.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 0.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.0 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.2 | 1.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.9 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.2 | 0.8 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.2 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.7 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.9 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 0.5 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.2 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.1 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 1.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.6 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.3 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.1 | 1.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.2 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.1 | 0.2 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0070404 | NADH binding(GO:0070404) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 1.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.9 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 2.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.0 | 0.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.0 | 0.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 3.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 1.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 4.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 4.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.7 | GO:0005262 | calcium channel activity(GO:0005262) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 5.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 1.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.4 |